Hi All,
My wish has come true. Riluzole concurrently with Monepantel.
This has somewhat changed from a Phase 1 , to a Phase 1b/2 trial.
Lumbar puncture assays on some participants. Bloods on others. Comparison of autophagic markers .
Evaluation of motor skill markers.
How many times have we failed a trial ?
On course again for another successful mission.
The true hope is we can make a positive outcome for our trial patients, and for the treatment of MND in general.
Well done to MND Foundation/PAA for providing us with an extremely useful webinar..
Ann: First Patient Dosed in MND Phase 1/2 Trial, page-138
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |